PHASE-II TRIAL OF DICHLOROMETHOTREXATE IN PATIENTS WITH ADVANCED SQUAMOUS-CELL CARCINOMA OF THE CERVIX - A GYNECOLOGIC-ONCOLOGY-GROUP STUDY

被引：0
|
作者：
ROBERTS, JA
BLESSING, JA
MCGEHEE, R
BEECHAM, J
HOMESLEY, HD
机构：
[1] NEW YORK STATE DEPT HLTH,ROSWELL PK MEM INST,GYNECOL ONCOL GRP,BUFFALO,NY 14263
[2] UNIV MISSISSIPPI,MED CTR,SCH MED,DIV GYNECOL ONCOL,JACKSON,MS 39216
[3] UNIV ROCHESTER,MED CTR,DIV GYNECOL ONCOL,ROCHESTER,NY 14642
[4] WAKE FOREST UNIV,BOWMAN GRAY SCH MED,DEPT OBSTET & GYNECOL,WINSTON SALEM,NC 27103
来源：
CANCER TREATMENT REPORTS | 1987年 / 71卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1295 / 1296
页数：2
相关论文
共 50 条
  • [41] A phase II trial of pyrazoloacridine (PZA) in squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study
    Plaxe, SC
    Blessing, JA
    Olt, G
    Husseinzadah, N
    Lentz, SS
    DeGeest, K
    Valea, FA
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2002, 50 (02) : 151 - 154
  • [42] PHASE-II TRIALS OF CISPLATIN AND PIPERAZINEDIONE IN ADVANCED OR RECURRENT SQUAMOUS-CELL CARCINOMA OF THE VULVA - A GYNECOLOGIC ONCOLOGY GROUP-STUDY
    THIGPEN, JT
    BLESSING, JA
    HOMESLEY, HD
    LEWIS, GC
    GYNECOLOGIC ONCOLOGY, 1986, 23 (03) : 358 - 363
  • [43] PHASE-II TRIAL OF ETOPOSIDE IN THE MANAGEMENT OF ADVANCED OR RECURRENT NON-SQUAMOUS CELL-CARCINOMA OF THE CERVIX - A GYNECOLOGIC ONCOLOGY GROUP-STUDY
    SLAYTON, RE
    BLESSING, JA
    HOMESLEY, HD
    CANCER TREATMENT REPORTS, 1984, 68 (12): : 1513 - 1514
  • [44] A Phase II study of topotecan in patients with squamous cell carcinoma of the cervix: A gynecologic oncology group study
    Muderspach, LI
    Blessing, JA
    Levenback, C
    Moore, JL
    GYNECOLOGIC ONCOLOGY, 2001, 81 (02) : 213 - 215
  • [45] PHASE-II TRIAL OF ETOPOSIDE IN THE MANAGEMENT OF ADVANCED AND RECURRENT LEIOMYOSARCOMA OF THE UTERUS - A GYNECOLOGIC-ONCOLOGY-GROUP STUDY
    SLAYTON, RE
    BLESSING, JA
    ANGEL, C
    BERMAN, M
    CANCER TREATMENT REPORTS, 1987, 71 (12): : 1303 - 1304
  • [46] PHASE-II STUDY OF FAZARABINE IN PATIENTS WITH ADVANCED OVARIAN-CANCER - A GYNECOLOGIC-ONCOLOGY-GROUP STUDY
    MANETTA, A
    BLESSING, JA
    LOOK, KY
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1995, 18 (02): : 156 - 157
  • [47] MITOXANTRONE (NSC-301739) IN PATIENTS WITH ADVANCED CERVICAL-CARCINOMA - A PHASE-II STUDY OF THE GYNECOLOGIC-ONCOLOGY-GROUP
    MUSS, HB
    SUTTON, GP
    BUNDY, B
    HATCH, KD
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1985, 8 (04): : 312 - 315
  • [48] Topotecan in squamous cell carcinoma of the cervix: A phase II study of the gynecologic oncology group
    Bookman, MA
    Blessing, JA
    Hanjani, P
    Herzog, TJ
    Andersen, WA
    GYNECOLOGIC ONCOLOGY, 2000, 77 (03) : 446 - 449
  • [49] MITOXANTRONE (NSC-301739) IN PATIENTS WITH ADVANCED OVARIAN-CARCINOMA - A PHASE-II STUDY OF THE GYNECOLOGIC-ONCOLOGY-GROUP
    MUSS, HB
    ASBURY, R
    BUNDY, B
    EHRLICH, CE
    GRAHAM, J
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1984, 7 (06): : 737 - 739
  • [50] AMINOTHIADIAZOLE (NSC-4728) IN PATIENTS WITH ADVANCED OVARIAN-CARCINOMA - A PHASE-II STUDY OF THE GYNECOLOGIC-ONCOLOGY-GROUP
    ASBURY, RF
    WILSON, J
    BLESSING, JA
    BUCHSBAUM, HJ
    DISAIA, PJ
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1986, 9 (04): : 334 - 336
12345